Business Context and Reporting Period
Company: Colgate-Palmolive Co.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
Business Overview: A leading global consumer products company operating in two primary segments: Oral, Personal and Home Care (86% of sales) and Pet Nutrition (14% of sales). Products are marketed in over 200 countries. The company employs approximately 36,000 people, 83% of whom are located outside the U.S.
Key Financial Metrics
| Metric (in millions, except per share) | 2004 | 2003 |
|---|---|---|
| Net Sales | $10,584.2 | $9,903.4 |
| Gross Profit | $5,837.0 | $5,447.3 |
| Gross Margin | 55.1% | 55.0% |
| Operating Profit | $2,122.1 | $2,166.0 |
| Net Income | $1,327.1 | $1,421.3 |
| Diluted EPS | $2.33 | $2.46 |
| Operating Cash Flow | $1,754.3 | $1,767.7 |
| Free Cash Flow (before dividends) | $1,406.2 | $1,465.6 |
| Total Debt | $3,675.1 | $3,102.9 |
| Long-Term Debt | $3,540.8 | $2,999.3 |
| Cash and Equivalents | $319.6 | $265.3 |
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 7.0% to $10.6 billion, driven by volume growth of 5.5% and a 3.0% positive foreign exchange impact. This was partially offset by a 1.5% decrease in net selling prices. The acquisition of GABA Holding AG contributed 1.0% to sales growth.
- Profitability Decline: Operating profit declined 2% to $2.1 billion. This decrease was primarily due to a $68.7 million pre-tax charge related to the 2004 Restructuring Program, increased raw material costs, and higher advertising/promotional spending.
- Net Income: Net income decreased 6.6% to $1.3 billion. The decline included an after-tax charge of $48.0 million ($0.09 per share) associated with the restructuring program.
- Segment Performance:
- Oral, Personal and Home Care: Sales up 6.5%; Operating profit up 4.0%.
- Pet Nutrition: Sales up 9.0%; Operating profit up 5.0%.
- Europe: Sales up 14.0% (driven by GABA acquisition and currency strength); Operating profit up 10.0%.
- North America: Sales up 1.0%; Operating profit down 3.0% due to higher costs and commercial investment.
- Debt Levels: Total debt increased by approximately $572 million, largely due to financing the GABA acquisition and increased commercial paper usage.
Guidance, Outlook, and Risks
2004 Restructuring Program
In December 2004, the company launched a four-year restructuring and business-building program. Key details include:
- Estimated Cost: Cumulative pre-tax charges of $750 million to $900 million ($550 million to $650 million after-tax).
- 2005 Impact: Estimated 2005 charges of $250 million to $325 million pre-tax. Projected 2005 savings of approximately $45 million after-tax.
- Long-term Savings: Projected annual savings of $325 million to $400 million by the fourth year.
- Scope: Includes rationalizing one-third of manufacturing facilities, closing warehouses, centralizing purchasing, and a 12% workforce reduction over four years.
Outlook
Management expects market conditions to remain highly competitive in 2005. The company anticipates prioritizing investments in key categories to build market share. Savings from the restructuring program are expected to fund new product development and support increased profitability.
Risks and Contingencies
- Brazilian Legal Proceedings: Significant ongoing litigation regarding the 1995 Kolynos acquisition.
- Central Bank Fine: A fine of approximately $100 million is suspended pending appeal.
- Tax Assessments: Disallowed interest deductions and foreign exchange losses totaling approximately $70 million are under appeal.
- Criminal Charges: Federal prosecutors authorized criminal charges against certain officers; management intends to defend vigorously.
- Foreign Currency: Exposure to currency fluctuations, particularly in Latin America and Europe, which can impact reported results.
- Commodity Prices: Volatility in raw material costs (e.g., tallow, essential oils) affects margins.
- Accounting Changes: Adoption of SFAS 123R (Share-Based Payment) effective July 1, 2005, is expected to increase compensation expense.
Investor Verification Checklist
- Restructuring Execution: Verify the actual costs and savings realized from the 2004 Restructuring Program against the $750M-$900M estimate.
- Brazil Litigation Resolution: Monitor the outcome of the Central Bank fine appeal and tax assessments, which could result in significant one-time charges if not resolved favorably.
- Margin Pressure: Assess the company's ability to offset rising raw material costs and promotional spending through pricing power or efficiency gains.
- Foreign Exchange Impact: Evaluate the sensitivity of future earnings to currency fluctuations, particularly the Euro and Latin American currencies.
- Stock Repurchases: Track the utilization of the $20 million share repurchase program authorized in October 2004.